Patrick Baeuerle's Net Worth
$11.2 Million
Who is Patrick Baeuerle?
Patrick Baeuerle has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include Cullinan Oncology, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., and MICROMET, INC..
SEC CIK
Patrick Baeuerle's CIK is 0001362054
Past Insider Trading and Trends
2019 was Patrick Baeuerle's most active year for acquiring shares with 3 total transactions. Patrick Baeuerle's most active month to acquire stocks was the month of January. 2012 was Patrick Baeuerle's most active year for disposing of shares, totalling 9 transactions. Patrick Baeuerle's most active month to dispose stocks was the month of February. 2021 saw Patrick Baeuerle paying a total of $94,600.00 for 308,665 shares, this is the most they've acquired in one year. In 2012 Patrick Baeuerle cashed out on 1,164,620 shares for a total of $8,630,572.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cullinan Oncology, Inc. (CGEM) Snapshot price: $18.47
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +102.67% | 38.5K |
—
|
—
| 76K |
Feb 17
| |||
Form 4
|
∞
| 37.5K |
—
|
—
| 37.5K |
Feb 11
| |||
Form 4
|
—
|
0
|
$16.38 | -$265,650.00 |
0
|
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$15.65 | -$249,700.00 |
0
|
Scheduled
|
Aug 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| -25.00% | -87.38K |
$15.98 | -$1,396,280.84 | 262.14K |
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| -25.00% | -116.93K |
$15.36 | -$1,796,417.60 | 350.79K |
Scheduled
|
Dec 20 - Dec 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MICROMET, INC. No price found
SVP, CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -100.00% | -16.27K |
$11.00 | -$178,926.00 |
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 22.56K |
—
|
—
| 22.56K |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||